Use of Thiazolidinone Derivatives as Antiangiogenic Agents
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 23, 2008
app pub date -
Dec 19, 2005
filing date -
Dec 23, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to the use of compounds of general formula (I), in which R.sub.1, R.sub.2 and X are as defined in the description for the preparation of pharmaceutical compositions for the treatment of pathologies in which inhibition of the interaction between HIF-1.alpha. and p300 is beneficial, in particular as antiangiogenic medicaments for the therapy of solid tumors.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully